-       Report 
   - April 2024
    -  30 Pages 
    Global
   
   From       €1977EUR$2,200USD£1,734GBP 
      €2472EUR$2,750USD£2,168GBP 
                  -       Report 
   - February 2023
    -  120 Pages 
    Global
   
   From       €5393EUR$6,000USD£4,730GBP 
      €6741EUR$7,500USD£5,912GBP 
                -       Report 
   - October 2022
    -  113 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                  -       Report 
   - May 2024
    -  139 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                  -       Report 
   - May 2024
    -  130 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                   -       Report 
   - May 2024
    -  140 Pages 
    Global
   
   From       €4965EUR$5,524USD£4,354GBP 
      €5841EUR$6,499USD£5,123GBP 
                -       Report 
   - March 2023
    -  117 Pages 
    Global
   
   From       €4045EUR$4,500USD£3,547GBP 
                -       Drug Pipelines 
   - September 2020
    -  96 Pages 
    Global
   
   From       €1798EUR$2,000USD£1,577GBP 
                -       Report 
   - April 2023
    -  160 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Report 
   - November 2020
    -  225 Pages 
    Global
   
   From       €13478EUR$14,995USD£11,820GBP 
                -       Report 
   - June 2024
    -  181 Pages 
    Global
   
   From       €4490EUR$4,995USD£3,937GBP 
                -       Report 
   - May 2021
    -  42 Pages 
    Global
   
        €1185EUR$1,318USD£1,039GBP 
                -       Report 
   - December 2023
    -  73 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - June 2023
    -  110 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - February 2022
    -  71 Pages 
    Global
   
   From       €3200EUR$3,814USD£2,905GBP 
                -       Report 
   - November 2021
    -  747 Pages 
    Global
   
   From       €3595EUR$4,000USD£3,153GBP 
             
         Somatostatin is a peptide hormone that is used in the treatment of various types of cancer. It is used to inhibit the release of growth hormones, which can help reduce the size of tumors. It is also used to reduce the side effects of chemotherapy and radiation therapy. Somatostatin is available in both injectable and oral forms. It is often used in combination with other drugs to treat cancer.
Somatostatin is used to treat a variety of cancers, including pancreatic, prostate, and neuroendocrine    tumors. It is also used to treat acromegaly, a condition caused by excessive growth hormone production. Somatostatin is also used to treat Cushing's syndrome, a condition caused by excessive cortisol production.
Some companies that produce somatostatin include Novartis, Merck, and Pfizer. Other companies that produce somatostatin-based drugs include Ipsen, Teva, and Sandoz. Show Less   Read more